Tag: Andreas Strüngmann
Record funding for biotech firm ITM
Laboratory at ITM The Munich company was able to collect more than 200 million euros from investors. (Photo: ITM) Frankfurt In one of the largest private investment rounds in the…
Biontech founders’ cancer drug convinces in study
Ugur Sahin and Özlem Türeci 2018 Before Biontech, Sahin and Türeci founded the Mainz-based biotech company Ganymed. Here they researched a gastric cancer drug whose effectiveness could be proven in…